Ghrelin Mimetic
A compound that mimics the action of ghrelin at the GHSR-1a receptor to stimulate growth hormone release and related metabolic effects.
Definition
A ghrelin mimetic is a compound that binds and activates the ghrelin receptor (GHSR-1a, growth hormone secretagogue receptor type 1a) to produce biological effects similar to those of endogenous ghrelin. Ghrelin is a 28-amino acid acylated peptide primarily produced in the stomach and is the endogenous ligand for GHSR-1a. Activation of GHSR-1a in pituitary somatotrophs stimulates GH secretion, while activation in hypothalamic and peripheral tissues produces additional effects including orexigenic signaling and metabolic regulation. Synthetic ghrelin mimetics are more stable than native ghrelin and are used as research tools to selectively probe GHSR-1a-mediated signaling.
Research Context
Ghrelin mimetics are studied in preclinical research primarily for their ability to stimulate GH secretion and to investigate the broader metabolic and neuroendocrine roles of GHSR-1a signaling. Ipamorelin, the ghrelin mimetic component of the CJC-1295/Ipamorelin research blend, is notable for its selectivity for GHSR-1a with minimal effects on other pituitary hormone axes. When combined with GHRH analogs in preclinical studies, ghrelin mimetics produce synergistic GH release through complementary receptor mechanisms.
Relevant Compounds
This term applies to the following research compound hubs.
Frequently Asked Questions
Explore the Research Library
Compound comparisons, research use cases, study indexes, and more. A complete reference for research-grade peptide science.